Gilead Sciences, Inc.
Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
Last updated:
Abstract:
Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
25 Jul 2018
Issue date:
13 Aug 2019